Arcturus Therapeutics Holdings, Inc.
(NASDAQ : ARCT)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.42%165.870.7%$1243.67m
PFEPfizer Inc. 1.97%37.270.9%$1193.22m
LLYEli Lilly & Co. 3.09%212.511.1%$1017.68m
ABBVAbbVie, Inc. -0.54%110.261.9%$759.26m
MRKMerck & Co., Inc. 0.20%81.140.7%$707.88m
AZNAstraZeneca Plc 1.43%54.011.2%$704.34m
BMYBristol-Myers Squibb Co. 0.42%64.831.0%$702.75m
ARCTArcturus Therapeutics Holdings, Inc. 2.57%69.440.0%$238.08m
VTRSViatris, Inc. -1.15%17.230.0%$198.15m
NVSNovartis AG 1.66%98.510.2%$189.98m
GRTSGritstone Oncology, Inc. -11.99%23.860.0%$188.77m
RPRXRoyalty Pharma Plc 0.67%51.500.2%$180.84m
GSKGlaxoSmithKline Plc 1.43%38.910.2%$162.00m
SNYSanofi -0.12%49.630.2%$138.94m
TAKTakeda Pharmaceutical Co., Ltd. 1.32%18.370.0%$81.25m

Company Profile

Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA.